{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:28:13Z","timestamp":1790674093879,"version":"4.1.0"},"reference-count":237,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003852","name":"Regione Campania","doi-asserted-by":"publisher","award":["PO FESR 2014-2020"],"award-info":[{"award-number":["PO FESR 2014-2020"]}],"id":[{"id":"10.13039\/501100003852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Melanoma is the less common but the most malignant skin cancer. Since the survival rate of melanoma metastasis is about 10\u201315%, many different studies have been carried out in order to find a more effective treatment. Although the development of target-based therapies and immunotherapeutic strategies has improved chances for patient survival, melanoma treatment still remains a big challenge for oncologists. Here, we collect recent data about the emerging role of melanoma-associated microRNAs (miRNAs) currently available treatments, and their involvement in drug resistance. We also reviewed miRNAs as prognostic factors, because of their chemical stability and resistance to RNase activity, in melanoma progression. Moreover, despite miRNAs being considered small conserved regulators with the limitation of target specificity, we outline the dual role of melanoma-associated miRNAs, as oncogenic and\/or tumor suppressive factors, compared to other tumors.<\/jats:p>","DOI":"10.3390\/ijms21030878","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T10:51:07Z","timestamp":1580295067000},"page":"878","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["The miRNAs Role in Melanoma and in Its Resistance to Therapy"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1820-5955","authenticated-orcid":false,"given":"Francesca","family":"Varrone","sequence":"first","affiliation":[{"name":"IRBM S.p.A., Via Pontina Km 30,600, I-00071 Pomezia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Caputo","sequence":"additional","affiliation":[{"name":"Institute of Genetics and Biophysics \u2013I.G.B., Adriano Buzzati-Traverso, Consiglio Nazionale delle Ricerche (CNR), Via Pietro Castellino, 111, I-80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11912-008-0067-y","article-title":"Melanoma and the tumor microenvironment","volume":"10","author":"Villanueva","year":"2008","journal-title":"Curr. Oncol. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1755-148X.2011.00834.x","article-title":"Generation of melanocytes from neural crest cells","volume":"24","author":"Sommer","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1755-148X.2010.00777.x","article-title":"Mouse melanoma models and cell lines","volume":"23","author":"Damsky","year":"2010","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0046-8177(84)80310-X","article-title":"A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma","volume":"15","author":"Clark","year":"1984","journal-title":"Hum. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/jnci\/88.23.1731","article-title":"KiSS-1, a novel human malignant melanoma metastasis-suppressor gene","volume":"88","author":"Lee","year":"1996","journal-title":"J. Natl. Cancer. Inst."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnci\/95.10.723","article-title":"p16\/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: Possible implications for melanoma progression","volume":"95","author":"Sviderskaya","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1038\/sj.onc.1206446","article-title":"Human melanocyte senescence and melanoma susceptibility genes","volume":"22","author":"Bennett","year":"2003","journal-title":"Oncogene"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Crispi, S., and Caputo, E. (2013). Gene Expression Profiling in Melanoma. Skin Cancer: A Practical Approach, Springer.","DOI":"10.1007\/978-1-4614-7357-2_36"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1755-148X.2007.00427.x","article-title":"Cancer stem cells and human malignant melanoma","volume":"21","author":"Schatton","year":"2008","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1158\/0008-5472.CAN-05-1343","article-title":"A tumorigenic subpopulation with stem cell properties in melanomas","volume":"65","author":"Fang","year":"2005","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc1092","article-title":"Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma","volume":"3","author":"Hendrix","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ejca.2007.01.017","article-title":"Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential","volume":"43","author":"Monzani","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jss.2007.03.053","article-title":"Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells","volume":"141","author":"Baumgartner","year":"2007","journal-title":"J. Surg. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1245\/s10434-007-9488-3","article-title":"Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients","volume":"14","author":"McCarter","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.4049\/jimmunol.173.2.1444","article-title":"Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells","volume":"173","author":"Viguier","year":"2004","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrg1748","article-title":"The epigenetic progenitor origin of human cancer","volume":"7","author":"Feinberg","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/PPO.0b013e31803c6e3b","article-title":"An epigenetic approach to cancer etiology","volume":"13","author":"Feinberg","year":"2007","journal-title":"Cancer J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.18632\/oncotarget.23989","article-title":"Genetic alterations in main candidate genes during melanoma progression","volume":"9","author":"Sini","year":"2018","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/CEJ.0000000000000334","article-title":"Vitamin D status and risk for malignant cutaneous melanoma: Recent advances","volume":"26","author":"Ombra","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199904293401707","article-title":"The pathogenesis of melanoma induced by ultraviolet radiation","volume":"340","author":"Gilchrest","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1038\/sj.onc.1206445","article-title":"Genetics of melanoma predisposition","volume":"22","author":"Hayward","year":"2003","journal-title":"Oncogene"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1038\/sj.onc.1206444","article-title":"Melanoma etiology: Where are we?","volume":"22","author":"Tucker","year":"2003","journal-title":"Oncogene"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1067\/mjd.2003.289","article-title":"Numerous, small, darkly pigmented melanocytic nevi: The cheetah phenotype","volume":"48","author":"Huynh","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2004.10.016","article-title":"Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Del Bino, S., Duval, C., and Bernerd, F. (2018). Clinical and Biological Characterization of Skin Pigmentation Diversity and Its Consequences on UV Impact. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092668"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1007\/s13277-014-1904-2","article-title":"Running for time: Circadian rhythms and melanoma","volume":"35","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11912-018-0733-7","article-title":"Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches","volume":"20","author":"Palmieri","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.celrep.2017.10.052","article-title":"Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines","volume":"21","author":"Garman","year":"2017","journal-title":"Cell Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.yexmp.2017.08.006","article-title":"Somatic mutation analysis in melanoma using targeted next generation sequencing","volume":"103","author":"Miraflor","year":"2017","journal-title":"Exp. Mol. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.5213","article-title":"Melanoma subtypes: Genomic profiles, prognostic molecular markers and therapeutic possibilities","volume":"247","author":"Rabbie","year":"2019","journal-title":"J. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1158\/1078-0432.CCR-05-2397","article-title":"Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses","volume":"12","author":"Reddy","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11912-012-0249-5","article-title":"Driver mutations in melanoma: Lessons learned from bench-to-bedside studies","volume":"14","author":"Mehnert","year":"2012","journal-title":"Curr. Oncol. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1158\/1535-7163.MCT-13-0804","article-title":"A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: A road map for the study of genes with potential clinical relevance","volume":"13","author":"Xia","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lokhandwala, P.M., Tseng, L.H., Rodriguez, E., Zheng, G., Pallavajjalla, A., Gocke, C.D., Eshleman, J.R., and Lin, M.T. (2019). Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5864-1"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"ref_39","first-page":"14","article-title":"Monoclonal antibodies in cancer therapy","volume":"12","author":"Scott","year":"2012","journal-title":"Cancer Immun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/v10019-010-0008-x","article-title":"Role of radiotherapy in melanoma management","volume":"44","author":"Strojan","year":"2010","journal-title":"Radiol. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41591-018-0197-1","article-title":"Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma","volume":"24","author":"Amaria","year":"2018","journal-title":"Nat. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1634\/theoncologist.2009-0237","article-title":"Long-term survival in patients with metastatic melanoma treated with DTIC or temozolomide","volume":"15","author":"Kim","year":"2010","journal-title":"Oncologist"},{"key":"ref_43","first-page":"488","article-title":"Treatment of metastatic melanoma: An overview","volume":"23","author":"Bhatia","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.4238\/2014.January.22.8","article-title":"Analysis of the BRAF V600E mutation in primary cutaneous melanoma","volume":"13","author":"Inumaru","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2010.32.4327","article-title":"Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma","volume":"29","author":"Long","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ejca.2012.11.019","article-title":"Resistance to BRAF-targeted therapy in melanoma","volume":"49","author":"Sullivan","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature05661","article-title":"Melanoma biology and new targeted therapy","volume":"445","author":"Wellbrock","year":"2007","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2011.41.2452","article-title":"BRAF\/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma","volume":"30","author":"Colombino","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_51","first-page":"291","article-title":"[Translational research and diagnostics of melanoma]","volume":"33","author":"Ruschoff","year":"2012","journal-title":"Pathologe"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.2147\/OTT.S182721","article-title":"Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma","volume":"11","author":"Kakadia","year":"2018","journal-title":"Onco. Targets Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40265-018-0884-8","article-title":"BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers","volume":"78","author":"Sanchez","year":"2018","journal-title":"Drugs"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ebiom.2019.09.023","article-title":"Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma","volume":"48","author":"Smalley","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbcan.2019.02.002","article-title":"Many ways to resistance: How melanoma cells evade targeted therapies","volume":"1871","author":"Kozar","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.18632\/oncotarget.1892","article-title":"Pathways and therapeutic targets in melanoma","volume":"5","author":"Shtivelman","year":"2014","journal-title":"Oncotarget"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.18632\/oncotarget.1202","article-title":"Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness","volume":"4","author":"Siemens","year":"2013","journal-title":"Oncotarget"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"vii339","DOI":"10.1093\/annonc\/mdq364","article-title":"Advances in systemic treatment of melanoma","volume":"21","author":"Eggermont","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13046-019-1259-z","article-title":"Combination of CTLA-4 and PD-1 blockers for treatment of cancer","volume":"38","author":"Rotte","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S1470-2045(18)30700-9","article-title":"Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial","volume":"19","author":"Hodi","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aau0417","article-title":"MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation","volume":"10","author":"Bommareddy","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fimmu.2019.00604","article-title":"Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect","volume":"10","author":"Suek","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/biomedicines2030211","article-title":"Toll-Like Receptor 9 Agonists for Cancer Therapy","volume":"2","author":"Melisi","year":"2014","journal-title":"Biomedicines"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.critrevonc.2018.11.002","article-title":"Advanced stage melanoma therapies: Detailing the present and exploring the future","volume":"133","author":"Luther","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.celrep.2019.07.106","article-title":"Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood","volume":"28","author":"Peng","year":"2019","journal-title":"Cell Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e000491","DOI":"10.1136\/esmoopen-2019-000491","article-title":"Tolerability of BRAF\/MEK inhibitor combinations: Adverse event evaluation and management","volume":"4","author":"Heinzerling","year":"2019","journal-title":"ESMO Open"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Abdel-Wahab, N., Shah, M., and Suarez-Almazor, M.E. (2016). Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160221"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e1052212","DOI":"10.1080\/2162402X.2015.1052212","article-title":"Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma","volume":"5","author":"Mok","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e1238557","DOI":"10.1080\/2162402X.2016.1238557","article-title":"Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma","volume":"5","author":"Deken","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41591-019-0476-5","article-title":"Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma","volume":"25","author":"Ribas","year":"2019","journal-title":"Nat. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The, C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.2964","article-title":"MicroRNA-9 up-regulates E-cadherin through inhibition of NF-kappaB1-Snail1 pathway in melanoma","volume":"226","author":"Liu","year":"2012","journal-title":"J. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jnci\/djt003","article-title":"The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression","volume":"105","author":"Dar","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"63901","DOI":"10.18632\/oncotarget.11564","article-title":"Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22","volume":"7","author":"Luan","year":"2016","journal-title":"Oncotarget"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1038\/cddiscovery.2017.28","article-title":"MicroRNA-26a inhibits the growth and invasiveness of malignant melanoma and directly targets on MITF gene","volume":"3","author":"Qian","year":"2017","journal-title":"Cell Death Discov."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/abr.abr_146_18","article-title":"miR-30a Inhibits Melanoma Tumor Metastasis by Targeting the E-cadherin and Zinc Finger E-box Binding Homeobox 2","volume":"7","author":"Noori","year":"2018","journal-title":"Adv. Biomed. Res."},{"key":"ref_79","first-page":"2492","article-title":"miR30a5p inhibits the proliferation, migration and invasion of melanoma cells by targeting SOX4","volume":"18","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1158\/0008-5472.CAN-08-2148","article-title":"MicroRNAs impair MET-mediated invasive growth","volume":"68","author":"Migliore","year":"2008","journal-title":"Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e1618","DOI":"10.1038\/cddis.2014.582","article-title":"MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET","volume":"6","author":"Li","year":"2015","journal-title":"Cell Death Dis"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1158\/0008-5472.CAN-07-2912","article-title":"MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines","volume":"68","author":"Bemis","year":"2008","journal-title":"Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"8393","DOI":"10.1002\/jcb.28124","article-title":"Mechanism of miR-137 regulating migration and invasion of melanoma cells by targeting PIK3R3 gene","volume":"120","author":"Qi","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Haflidadottir, B.S., Bergsteinsdottir, K., Praetorius, C., and Steingrimsson, E. (2010). miR-148 regulates Mitf in melanoma cells. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011574"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1292\/jvms.11-0264","article-title":"Comparative study of anti-oncogenic microRNA-145 in canine and human malignant melanoma","volume":"74","author":"Noguchi","year":"2012","journal-title":"J. Vet. Med. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Qiu, H., Chen, F., and Chen, M. (2019). MicroRNA-138 negatively regulates the hypoxia-inducible factor 1alpha to suppress melanoma growth and metastasis. Biol. Open, 8.","DOI":"10.1242\/bio.042937"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.3892\/etm.2016.3220","article-title":"MicroRNA-138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF-1alpha","volume":"11","author":"Chen","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2019.05.111","article-title":"MiR-150\u20135p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg Effect","volume":"515","author":"Yang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"13244","DOI":"10.18632\/oncotarget.24284","article-title":"miR-128 inhibits telomerase activity by targeting TERT mRNA","volume":"9","author":"Guzman","year":"2018","journal-title":"Oncotarget"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/carcin\/bgv085","article-title":"Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit","volume":"36","author":"Zhang","year":"2015","journal-title":"Carcinogenesis"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.2353\/ajpath.2010.091061","article-title":"MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma","volume":"176","author":"Chen","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"32507","DOI":"10.18632\/oncotarget.25986","article-title":"miR-193b and miR-30c-1(*) inhibit, whereas miR-576\u20135p enhances melanoma cell invasion in vitro","volume":"9","author":"Kordass","year":"2018","journal-title":"Oncotarget"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13148-018-0600-2","article-title":"Demethylation by low-dose 5-aza-2\u2019-deoxycytidine impairs 3D melanoma invasion partially through miR-199a-3p expression revealing the role of this miR in melanoma","volume":"11","author":"Desjobert","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Jin, C., Wang, A., Liu, L., Wang, G., Li, G., and Han, Z. (2019). miR-145-5p inhibits tumor occurrence and metastasis through the NF-kappaB signaling pathway by targeting TLR4 in malignant melanoma. J. Cell Biochem.","DOI":"10.1002\/jcb.28388"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.biopha.2016.09.022","article-title":"Upregulation of miR-124 by physcion 8-O-beta-glucopyranoside inhibits proliferation and invasion of malignant melanoma cells via repressing RLIP76","volume":"84","author":"Zhang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1038\/onc.2012.307","article-title":"MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression","volume":"32","author":"Kappelmann","year":"2013","journal-title":"Oncogene"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1755-148X.2011.00857.x","article-title":"MicroRNA-155 targets the SKI gene in human melanoma cell lines","volume":"24","author":"Levati","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1158\/1541-7786.MCR-15-0425-T","article-title":"miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization","volume":"14","author":"Raimo","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e01460","DOI":"10.7554\/eLife.01460","article-title":"miR-146a promotes the initiation and progression of melanoma by activating Notch signaling","volume":"3","author":"Forloni","year":"2014","journal-title":"Elife"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3892\/or.2016.5020","article-title":"miR-194 is a negative regulator of GEF-H1 pathway in melanoma","volume":"36","author":"Guo","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1479-5876-11-218","article-title":"MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab","volume":"11","author":"Wagenseller","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.ajpath.2012.07.009","article-title":"miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1","volume":"181","author":"Liu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"16606","DOI":"10.1074\/jbc.M111.227611","article-title":"miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein","volume":"286","author":"Dar","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Margue, C., Philippidou, D., Reinsbach, S.E., Schmitt, M., Behrmann, I., and Kreis, S. (2013). New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073473"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbrc.2014.11.087","article-title":"MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1","volume":"456","author":"Chang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jid.2017.09.049","article-title":"Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis","volume":"138","author":"Lohcharoenkal","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"20193","DOI":"10.1002\/jcp.28619","article-title":"MicroRNA-203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo","volume":"234","author":"Sahranavardfard","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/vco.12118","article-title":"Analysis of microRNA-203 function in CREB\/MITF\/RAB27a pathway: Comparison between canine and human melanoma cells","volume":"14","author":"Noguchi","year":"2016","journal-title":"Vet. Comp. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"8007","DOI":"10.1007\/s13277-014-2079-6","article-title":"Expression patterns of microRNA-218 and its potential functions by targeting CIP2A and BMI1 genes in melanoma","volume":"35","author":"Wei","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"12412","DOI":"10.1002\/jcb.28507","article-title":"miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3\/AKT3 in uveal melanoma","volume":"120","author":"Li","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_111","first-page":"4913","article-title":"MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression","volume":"8","author":"Bai","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1158\/0008-5472.CAN-15-2932","article-title":"miR-339-3p Is a Tumor Suppressor in Melanoma","volume":"76","author":"Weber","year":"2016","journal-title":"Cancer Res."},{"key":"ref_113","first-page":"997","article-title":"MicroRNA-338-3p suppresses cell proliferation, migration and invasion in human malignant melanoma by targeting MACC1","volume":"18","author":"Zhang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1074\/jbc.M114.590158","article-title":"MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by coding region determinant-binding protein (CRD-BP)","volume":"290","author":"Goswami","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/CBM-190289","article-title":"MicroRNA-429 inhibits cancer cell proliferation and migration by targeting the AKT1 in melanoma","volume":"26","author":"Huang","year":"2019","journal-title":"Cancer Biomark."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"E5005-13","DOI":"10.1073\/pnas.1607753113","article-title":"miR-579-3p controls melanoma progression and resistance to target therapy","volume":"113","author":"Fattore","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"9444","DOI":"10.18632\/oncotarget.2452","article-title":"miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbrc.2016.04.093","article-title":"miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine\/threonine protein kinase, PIM1, in melanoma","volume":"474","author":"Rang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3892\/or.2017.5740","article-title":"MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma","volume":"38","author":"Chen","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_120","first-page":"3372","article-title":"MicroRNA675 inhibits cell proliferation and invasion in melanoma by directly targeting metadherin","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1038\/onc.2008.282","article-title":"Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma","volume":"27","author":"Muller","year":"2008","journal-title":"Oncogene"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/cr.2008.45","article-title":"MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth","volume":"18","author":"Schultz","year":"2008","journal-title":"Cell Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.gene.2019.05.043","article-title":"miR-10b promoted melanoma progression through Wnt\/beta-catenin pathway by repressing ITCH expression","volume":"710","author":"Wang","year":"2019","journal-title":"Gene"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"19006","DOI":"10.18632\/oncotarget.4147","article-title":"miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1","volume":"6","author":"Cohen","year":"2015","journal-title":"Oncotarget"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1038\/srep08201","article-title":"miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells","volume":"5","author":"Ohira","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Martin del Campo, S.E., Latchana, N., Levine, K.M., Grignol, V.P., Fairchild, E.T., Jaime-Ramirez, A.C., Dao, T.V., Karpa, V.I., Carson, M., and Ganju, A. (2015). MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: In vivo effects of MiR-21 inhibitor. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0115919"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"39172","DOI":"10.1074\/jbc.M111.285098","article-title":"MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells","volume":"286","author":"Yang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/CMR.0000000000000216","article-title":"MicroRNA-21 expression and its pathogenetic significance in cutaneous melanoma","volume":"26","author":"Saldanha","year":"2016","journal-title":"Melanoma Res."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Huo, J., Zhang, Y., Li, R., Wang, Y., Wu, J., and Zhang, D. (2016). Upregulated MicroRNA-25 Mediates the Migration of Melanoma Cells by Targeting DKK3 through the WNT\/beta-Catenin Pathway. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17111124"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Jiang, Q.Q., and Liu, W.B. (2018). miR-25 Promotes Melanoma Progression by regulating RNA binding motif protein 47. Med. Sci. (Paris).","DOI":"10.1051\/medsci\/201834f111"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccr.2011.05.027","article-title":"miR-30b\/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis","volume":"20","author":"Segura","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jid.2016.02.803","article-title":"Regulation of Melanoma Progression through the TCF4\/miR-125b\/NEDD9 Cascade","volume":"136","author":"Rambow","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.0808263106","article-title":"Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor","volume":"106","author":"Segura","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/emboj.2011.102","article-title":"microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C","volume":"30","author":"Penna","year":"2011","journal-title":"EMBO J."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.15252\/embr.201439392","article-title":"E2F1 induces miR-224\/452 expression to drive EMT through TXNIP downregulation","volume":"15","author":"Knoll","year":"2014","journal-title":"EMBO Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cell.2012.10.028","article-title":"Convergent multi-miRNA targeting of ApoE drives LRP1\/LRP8-dependent melanoma metastasis and angiogenesis","volume":"151","author":"Pencheva","year":"2012","journal-title":"Cell"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12967-016-0811-2","article-title":"Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma","volume":"14","author":"Felicetti","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1158\/0008-5472.CAN-07-2538","article-title":"The promyelocytic leukemia zinc finger-microRNA-221\/-222 pathway controls melanoma progression through multiple oncogenic mechanisms","volume":"68","author":"Felicetti","year":"2008","journal-title":"Cancer Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/156652412798376170","article-title":"miR221\/222 in cancer: Their role in tumor progression and response to therapy","volume":"12","author":"Garofalo","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"ref_140","first-page":"4759","article-title":"MicroRNA-373 promotes cell migration via targeting salt-inducible kinase 1 expression in melanoma","volume":"16","author":"Bai","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/0008-5472.CAN-17-1933","article-title":"miR-519d Promotes Melanoma Progression by Downregulating EphA4","volume":"78","author":"Hua","year":"2018","journal-title":"Cancer Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1158\/1078-0432.CCR-08-3172","article-title":"Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma","volume":"15","author":"Kitago","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.18632\/oncotarget.3070","article-title":"miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy","volume":"6","author":"Bhattacharya","year":"2015","journal-title":"Oncotarget"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"10909","DOI":"10.1038\/s41598-017-11366-y","article-title":"MITF and BRN2 contribute to metastatic growth after dissemination of melanoma","volume":"7","author":"Simmons","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1101\/gad.406406","article-title":"Mitf regulation of Dia1 controls melanoma proliferation and invasiveness","volume":"20","author":"Carreira","year":"2006","journal-title":"Genes Dev."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1158\/0008-5472.CAN-08-1053","article-title":"Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells","volume":"68","author":"Goodall","year":"2008","journal-title":"Cancer Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1755-148X.2008.00505.x","article-title":"Novel MITF targets identified using a two-step DNA microarray strategy","volume":"21","author":"Hoek","year":"2008","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/onc.2010.641","article-title":"Commentary. A picture of Mitf in melanoma immortality","volume":"30","author":"Goding","year":"2011","journal-title":"Oncogene"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4161\/rna.28865","article-title":"MicroRNA-218 inhibits melanogenesis by directly suppressing microphthalmia-associated transcription factor expression","volume":"11","author":"Guo","year":"2014","journal-title":"RNA Biol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2013.08.021","article-title":"MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2","volume":"341","author":"Luo","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/jid.2013.340","article-title":"Transcription factor\/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1","volume":"134","author":"Bell","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0749.1993.tb00576.x","article-title":"In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue, and fibroblasts","volume":"6","author":"Thomson","year":"1993","journal-title":"Pigment Cell Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1755-148X.2011.00849.x","article-title":"Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor","volume":"24","author":"Boyle","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1755-148X.2007.00433.x","article-title":"How to make a melanoma: What do we know of the primary clonal events?","volume":"21","author":"Bennett","year":"2008","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.3892\/or.2017.5963","article-title":"Phenotype characterization of human melanoma cells resistant to dabrafenib","volume":"38","author":"Cordaro","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Noguchi, K., Dalton, A.C., Howley, B.V., McCall, B.J., Yoshida, A., Diehl, J.A., and Howe, P.H. (2017). Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177830"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/pcmr.12379","article-title":"miR-200c\/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment","volume":"28","author":"Liu","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/jid.2015.105","article-title":"MITF Modulates Therapeutic Resistance through EGFR Signaling","volume":"135","author":"Ji","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"53558","DOI":"10.18632\/oncotarget.10669","article-title":"miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR\/IGF-1R\/CRAF and inhibiting the MAPK and PI3K\/AKT signaling pathways","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.bbrc.2018.06.175","article-title":"The miR-31-SOX10 axis regulates tumor growth and chemotherapy resistance of melanoma via PI3K\/AKT pathway","volume":"503","author":"Zheng","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Mishra, P.J., Mishra, P.J., and Merlino, G. (2016). Integrated Genomics Identifies miR-32\/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0165102"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s13046-019-1238-4","article-title":"miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A","volume":"38","author":"Caporali","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41418-018-0205-5","article-title":"Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma","volume":"26","author":"Fattore","year":"2019","journal-title":"Cell Death Differ."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13148-015-0092-2","article-title":"MicroRNA expression profiling predicts clinical outcome of carboplatin\/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603","volume":"7","author":"Villaruz","year":"2015","journal-title":"Clin. Epigenetics"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.18632\/oncotarget.6599","article-title":"Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b","volume":"7","author":"Vergani","year":"2016","journal-title":"Oncotarget"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Li, Y., Zhang, J., Liu, Y., Zhang, B., Zhong, F., Wang, S., and Fang, Z. (2018). MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4233-9"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/pcmr.12578","article-title":"MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway","volume":"30","author":"Hanniford","year":"2017","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"35374","DOI":"10.18632\/oncotarget.26244","article-title":"New insights in melanoma resistance to BRAF inhibitors: A role for microRNAs","volume":"9","author":"Teixido","year":"2018","journal-title":"Oncotarget"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"248","DOI":"10.18632\/oncoscience.443","article-title":"Biological role of miR-204 and miR-211 in melanoma","volume":"5","author":"Vitiello","year":"2018","journal-title":"Oncoscience"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ebiom.2015.05.011","article-title":"The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis","volume":"2","author":"Stark","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1172\/JCI98060","article-title":"Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma","volume":"128","author":"Huber","year":"2018","journal-title":"J. Clin. Invest."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00262-016-1898-2","article-title":"Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: A case report from a phase III trial","volume":"65","author":"Ascierto","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.cell.2006.02.037","article-title":"A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors","volume":"124","author":"Voorhoeve","year":"2006","journal-title":"Cell"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"15894","DOI":"10.18632\/oncotarget.15213","article-title":"PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p","volume":"8","author":"Audrito","year":"2017","journal-title":"Oncotarget"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"22262","DOI":"10.18632\/oncotarget.14763","article-title":"MicroRNAs in melanoma development and resistance to target therapy","volume":"8","author":"Fattore","year":"2017","journal-title":"Oncotarget"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"53735","DOI":"10.18632\/oncotarget.10731","article-title":"miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.20892\/j.issn.2095-3941.2018.0006","article-title":"Key questions about the checkpoint blockade-are microRNAs an answer?","volume":"15","author":"Dragomir","year":"2018","journal-title":"Cancer Biol. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/0008-5472.CAN-11-1977","article-title":"Tumor suppressive microRNAs miR-34a\/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D","volume":"72","author":"Heinemann","year":"2012","journal-title":"Cancer Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/0008-5472.CAN-18-1397","article-title":"miR-146a Controls Immune Response in the Melanoma Microenvironment","volume":"79","author":"Mastroianni","year":"2019","journal-title":"Cancer Res."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Arts, N., Cane, S., Hennequart, M., Lamy, J., Bommer, G., Van den Eynde, B., and De Plaen, E. (2015). microRNA-155, induced by interleukin-1ss, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122517"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.jid.2017.03.039","article-title":"MiR-200a Regulates CDK4\/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma","volume":"137","author":"Bustos","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1158\/0008-5472.CAN-12-1383","article-title":"Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells","volume":"72","author":"Noman","year":"2012","journal-title":"Cancer Res."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Eichmuller, S.B., Osen, W., Mandelboim, O., and Seliger, B. (2017). Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape. J. Natl. Cancer Inst., 109.","DOI":"10.1093\/jnci\/djx034"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.4049\/jimmunol.1103505","article-title":"MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN","volume":"188","author":"Liu","year":"2012","journal-title":"J. Immunol."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Ward, W.H., and Farma, J.M. (2017). Biomarkers in Malignant Melanoma: Recent Trends and Critical Perspective. Cutaneous Melanoma: Etiology and Therapy, Cadon Publications.","DOI":"10.15586\/codon.cutaneousmelanoma.2017"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1385\/MO:21:2:179","article-title":"The comparison of spontaneous LDH release activity from cultured PBMC with sera LDH activity in non-Hodgkin\u2019s lymphoma patients","volume":"21","author":"Jurisic","year":"2004","journal-title":"Med. Oncol."},{"key":"ref_191","first-page":"158","article-title":"Biomarker value and pitfalls of serum S100B in the follow-up of high-risk melanoma patients","volume":"14","author":"Gebhardt","year":"2016","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fonc.2014.00383","article-title":"Evaluating biomarkers in melanoma","volume":"4","author":"Karagiannis","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/978-1-62703-727-3_34","article-title":"Isolation of circulating microRNAs from microvesicles found in human plasma","volume":"1102","author":"Quackenbush","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3816\/CLC.2009.n.006","article-title":"Exosomal microRNA: A diagnostic marker for lung cancer","volume":"10","author":"Rabinowits","year":"2009","journal-title":"Clin. Lung Cancer"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Leidinger, P., Keller, A., Borries, A., Reichrath, J., Rass, K., Jager, S.U., Lenhof, H.P., and Meese, E. (2010). High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-262"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3892\/ijo.2012.1647","article-title":"Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (review)","volume":"41","author":"Allegra","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/carcin\/bgs205","article-title":"MicroRNA and cutaneous melanoma: From discovery to prognosis and therapy","volume":"33","author":"Segura","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1373\/clinchem.2008.112805","article-title":"MicroRNAs: Novel biomarkers for human cancer","volume":"55","author":"Bartels","year":"2009","journal-title":"Clin. Chem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/14712590902932889","article-title":"MicroRNA identification in plasma and serum: A new tool to diagnose and monitor diseases","volume":"9","author":"Cortez","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"12110","DOI":"10.18632\/oncotarget.3661","article-title":"Comparison of a healthy miRNome with melanoma patient miRNomes: Are microRNAs suitable serum biomarkers for cancer?","volume":"6","author":"Margue","year":"2015","journal-title":"Oncotarget"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jdermsci.2010.12.010","article-title":"The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker","volume":"61","author":"Kanemaru","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.molonc.2014.02.009","article-title":"The validity of circulating microRNAs in oncology: Five years of challenges and contradictions","volume":"8","author":"Jarry","year":"2014","journal-title":"Mol. Oncol."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Mumford, S.L., Towler, B.P., Pashler, A.L., Gilleard, O., Martin, Y., and Newbury, S.F. (2018). Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine. Biomolecules, 8.","DOI":"10.3390\/biom8020021"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jid.2019.06.126","article-title":"MicroRNA ratios distinguish melanomas from nevi","volume":"140","author":"Torres","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Seashols-Williams, S.J., Budd, W., Clark, G.C., Wu, Q., Daniel, R., Dragoescu, E., and Zehner, Z.E. (2016). miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159601"},{"key":"ref_207","first-page":"1797","article-title":"Overexpression of microRNA21 inhibits the growth and metastasis of melanoma cells by targeting MKK3","volume":"20","author":"Zhou","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Wang, H., Tan, Z., Hu, H., Liu, H., Wu, T., Zheng, C., Wang, X., Luo, Z., Wang, J., and Liu, S. (2019). microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5951-3"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.21037\/jtd.2019.07.50","article-title":"miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma","volume":"11","author":"Xu","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.3748\/wjg.v21.i31.9337","article-title":"MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer","volume":"21","author":"Tian","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_211","first-page":"203","article-title":"Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E","volume":"33","author":"Song","year":"2018","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cellsig.2013.01.028","article-title":"MiR-30d induces apoptosis and is regulated by the Akt\/FOXO pathway in renal cell carcinoma","volume":"25","author":"Wu","year":"2013","journal-title":"Cell Signal"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1478-811X-12-30","article-title":"Good guy or bad guy: The opposing roles of microRNA 125b in cancer","volume":"12","author":"Edbauer","year":"2014","journal-title":"Cell Commun. Signal."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bcp.2014.12.020","article-title":"Telmisartan attenuates the inflamed mesenteric adipose tissue in spontaneous colitis by mechanisms involving regulation of neurotensin\/microRNA-155 pathway","volume":"93","author":"Li","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.febslet.2013.03.023","article-title":"MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1","volume":"587","author":"Qin","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/mc.22365","article-title":"Progression of mouse skin carcinogenesis is associated with the orchestrated deregulation of mir-200 family members, mir-205 and their common targets","volume":"55","author":"Skourti","year":"2016","journal-title":"Mol. Carcinog."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1158\/0008-5472.CAN-13-0297","article-title":"miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer","volume":"73","author":"Cai","year":"2013","journal-title":"Cancer Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4161\/cc.11.4.19228","article-title":"MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN","volume":"11","author":"Qu","year":"2012","journal-title":"Cell Cycle"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1158\/0008-5472.CAN-08-2894","article-title":"miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon","volume":"69","author":"Gandellini","year":"2009","journal-title":"Cancer Res."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/cr.2009.18","article-title":"Suppression of cell growth and invasion by miR-205 in breast cancer","volume":"19","author":"Wu","year":"2009","journal-title":"Cell Res."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Golan, T., Parikh, R., Jacob, E., Vaknine, H., Zemser-Werner, V., Hershkovitz, D., Malcov, H., Leibou, S., Reichman, H., and Sheinboim, D. (2019). Adipocytes sensitize melanoma cells to environmental TGF-beta cues by repressing the expression of miR-211. Sci. Signal., 12.","DOI":"10.1126\/scisignal.aav6847"},{"key":"ref_222","first-page":"3171","article-title":"Downregulation of miR2245p in prostate cancer and its relevant molecular mechanism via TCGA, GEO database and in silico analyses","volume":"40","author":"Gan","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13046-018-0879-z","article-title":"MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt\/beta-catenin positive feedback loop","volume":"37","author":"Li","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_224","first-page":"6895","article-title":"MicroRNA-542-3p suppresses tumor cell proliferation via targeting Smad2 inhuman osteosarcoma","volume":"15","author":"Wu","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"42761","DOI":"10.18632\/oncotarget.6199","article-title":"MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1","volume":"6","author":"Cheng","year":"2015","journal-title":"Oncotarget"},{"key":"ref_226","first-page":"1175","article-title":"miR-205 regulates A549 cells proliferation by targeting PTEN","volume":"8","author":"Bai","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bjc.2011.568","article-title":"Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors","volume":"106","author":"Xu","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3892\/or.2011.1588","article-title":"MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A","volume":"27","author":"Yue","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_229","first-page":"2053","article-title":"MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1)","volume":"7","author":"Li","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.0808042106","article-title":"p53 represses c-Myc through induction of the tumor suppressor miR-145","volume":"106","author":"Sachdeva","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/bjc.2016.95","article-title":"Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer","volume":"114","author":"Goto","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.biopha.2018.11.104","article-title":"MiR-542-3p, a microRNA targeting CDK14, suppresses cell proliferation, invasiveness, and tumorigenesis of epithelial ovarian cancer","volume":"110","author":"Li","year":"2019","journal-title":"Biomed. Pharm."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"81062","DOI":"10.18632\/oncotarget.19009","article-title":"MicroRNAs with prognostic significance in osteosarcoma: A systemic review and meta-analysis","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ebiom.2016.09.017","article-title":"microRNA Therapeutics in Cancer\u2014An Emerging Concept","volume":"12","author":"Shah","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Mercatelli, N., Coppola, V., Bonci, D., Miele, F., Costantini, A., Guadagnoli, M., Bonanno, E., Muto, G., Frajese, G.V., and De Maria, R. (2008). The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0004029"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2014.05.009","article-title":"In vivo delivery of miRNAs for cancer therapy: Challenges and strategies","volume":"81","author":"Chen","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40169-018-0211-8","article-title":"Combination therapy to checkmate Glioblastoma: Clinical challenges and advances","volume":"7","author":"Ghosh","year":"2018","journal-title":"Clin. Transl. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/3\/878\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:53:04Z","timestamp":1760172784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/3\/878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":237,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["ijms21030878"],"URL":"https:\/\/doi.org\/10.3390\/ijms21030878","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]}}}